Clinical Trial Update: Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing S-1 to pemetrexed as maintenance therapy in advanced non-small cell lung cancer is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• Pemetrexed (pemetrexed)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: UNKNOWN